Article
No difference in leprosy treatment outcomes comparing 12- and 24-dose multidrug regimens: a preliminary study
Nenhuma diferença na evolução da hanseníase entre os esquemas terapêuticos de 12 versus 24 doses: um estudo preliminar
Registro en:
SALES, Anna Maria et al. No difference in leprosy treatment outcomes comparing 12- and 24-dose multidrug regimens: a preliminary study. Cadernos de Saúde Pública, v. 23, n. 4, p. 815-822, abr. 2007.
0102-311X
10.1590/S0102-311X2007000400009
1678-4464
Autor
Sales, Anna Maria
Sabroza, Paulo Chagastelles
Nery, José Augusto da Costa
Duppre, Nádia Cristina
Sarno, Euzenir Nunes
Resumen
A comparative study was performed on the initial and final bacillary indexes of 213 multibacillary leprosy patients who received 12 doses
(Group 1: 128 patients) or 24 doses (Group 2: 85 patients) of multidrug therapy (MDT/WHO) to measure the effectiveness of the two regimens.
All patients were evaluated at treatment baseline, 12 months, and 24 months. The reduction in bacillary levels and mean bacillary indexes
at 24 months was similar in the two groups. No statistical difference in reaction rates was observed between the two treatment regimens.